Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Accenture
Dow
US Department of Justice
McKinsey
Covington
Argus Health
Medtronic
QuintilesIMS

Generated: May 26, 2018

DrugPatentWatch Database Preview

ORETICYL 50 Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Oreticyl 50 patents expire, and when can generic versions of Oreticyl 50 launch?

Oreticyl 50 is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in ORETICYL 50 is deserpidine; hydrochlorothiazide. There are four drug master file entries for this compound. Additional details are available on the deserpidine; hydrochlorothiazide profile page.
Summary for ORETICYL 50
Drug patent expirations by year for ORETICYL 50
Synonyms for ORETICYL 50
(1S,2R,3R,4aS,13bR,14aS)-Methyl 2-methoxy-3-((3,4,5-trimethoxybenzoyl)oxy)-1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydroindolo[2',3'
(1S,2R,3R,4aS,13bR,14aS)-Methyl 2-methoxy-3-((3,4,5-trimethoxybenzoyl)oxy)-1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydroindolo[2',3':3,4]pyrido[1,2-b]isoquinoline-1-carboxylate
(3beta,16beta,17alpha,18beta,20alpha)-17-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester
11-Demethoxyreserpine
11-Desmethoxyreserpine
131-01-1
131D011
17.alpha.-Methoxy-18.beta.-[(3,4,5-trimethoxybenzoyl)oxy]-3.beta.,20.alpha.-yohimban-16.beta.-carboxylic acid methyl ester
3-beta,20-alpha-Yohimban-16-beta-carboxylic acid, 18-beta-hydroxy-17-alpha-methoxy-, methyl ester, 3,4,5-trimethoxybenzoate (ester)
3-beta,20-alpha-Yohimban-16-beta-carboxylic acid, 18-beta-hydroxy-17-alpha-methoxy-,methyl ester, 3,4,5-trimethoxybenzoate (ester)
4-25-00-01282 (Beilstein Handbook Reference)
9016E3VB47
A-11025
AC1L1R81
AC1Q5YIY
AK-57511
AKOS015896464
AN-43665
Benz[g]indolo[2, 1,2,3,4,4a,5,7,8,-13,13b,14,14a-dodecahydro-3-hydroxy-2-methoxy-, methyl ester, 3,4,5-trimethoxybenzoate
Benz[g]indolo[2,3-a]quinolizine-1-carboxylic acid, 1,2,3,4,4a,5,7,8,-13,13b,14,14a-dodecahydro-3-hydroxy-2-methoxy-, methyl ester, 3,4,5-trimethoxybenzoate
BRN 0101820
C-23656
C06541
C32H38N2O8
Canescin
Canescine
CAS-131-01-1
CC-26344
CHEBI:27478
CHEMBL1200515
D08194
D09HDR
DB01089
Deresperine
Desepridine
Deserpidic acid, methyl ester, 3,4,5-trimethoxybenzoate
Deserpidin
Deserpidina
Deserpidina [INN-Spanish]
DESERPIDINE
Deserpidine (INN)
Deserpidine [INN:BAN]
Deserpidinum
Deserpidinum [INN-Latin]
Desmethoxyreserpine
DR003308
DSSTox_CID_383
DSSTox_GSID_20383
DSSTox_RID_75556
DTXSID8020383
EINECS 205-004-8
GTPL7064
Halmonyl
Halmonyl (TN)
Harmonyl
I06-1877
J-005923
Lilly 22641
LS-7299
MD-0232
methyl (1R,15S,17R,18R,19S,20S)-18-methoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate
methyl (1R,15S,17R,18R,19S,20S)-18-methoxy-17-(3,4,5-trimethoxybenzoyloxy)-3,13-diazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-2(10),4,6,8-tetraene-19-carboxylate
METHYL (1R,15S,17R,18R,19S,20S)-18-METHOXY-17-(3,4,5-TRIMETHOXYBENZOYLOXY)-3,13-DIAZAPENTACYCLO[11.8.0.0(2),(1)?.0?,?.0(1)?,(2)?]HENICOSA-2(10),4,6,8-TETRAENE-19-CARBOXYLATE
METHYL (1R,15S,17R,18R,19S,20S)-18-METHOXY-17-(3,4,5-TRIMETHOXYBENZOYLOXY)-3,13-DIAZAPENTACYCLO[11.8.0.0(2),(1)?.0?,?.0(1)?,(2)?]HENICOSA-2(10),4(9),5,7-TETRAENE-19-CARBOXYLATE
methyl (1R,15S,17R,18R,19S,20S)-18-methoxy-17-[(3,4,5-trimethoxyphenyl)carbonyloxy]-3,13-diazapentacyclo[11.8.0.0;{2,10}.0;{4,9}.0;{15,20}]henicosa-2(10),4,6,8-tetraene-19-carboxylate
methyl (3beta,16beta,17alpha,18beta,20alpha)-17-(methyloxy)-18-({[3,4,5-tris(methyloxy)phenyl]carbonyl}oxy)yohimban-16-carboxylate
methyl (3beta,16beta,17alpha,18beta,20alpha)-17-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylate
Methyl 17alpha-methoxy-18beta-((3,4,5-trimethoxybenzoyl)oxy)-3beta,20alpha-yohimban-16beta-carboxylate
Methyl 17alpha-methoxy-18beta-(3,4,5-trimethoxybenzoyloxy)-3beta,20alpha-yohimban-16beta-carboxylat
Methyl 18beta-hydroxy-17alpha-methoxy-3beta,20alpha-yohimban-16beta-carboxylate, 3,4,5-trimethoxybenzoate (ester)
MLS006010113
MolPort-006-110-868
NCGC00168786-01
NCGC00168786-02
NSC 72138
NSC-72138
NSC72138
PL010830
PL044351
Raunormin
Raunormine
Recanescin
Recanescine
Reserpidine
SCHEMBL259343
SMR004701248
ST24033631
Tox21_112646
Tox21_113102
Tranquinil
UNII-9016E3VB47
Yohimban-16-carboxylic acid, 17-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-, methyl ester, (3b,16b,17a,18b,20a)-
ZINC4097186

US Patents and Regulatory Information for ORETICYL 50

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie ORETICYL 50 deserpidine; hydrochlorothiazide TABLET;ORAL 012148-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Moodys
Fish and Richardson
Cantor Fitzgerald
Mallinckrodt
Dow
Teva
Baxter
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.